➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
AstraZeneca
Medtronic
Boehringer Ingelheim

Last Updated: June 17, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Landiolol


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Landiolol?

Landiolol is an investigational drug.

There have been 7 clinical trials for Landiolol. The most recent clinical trial was a Phase 1 trial, which was initiated on December 13th 2019.

The most common disease conditions in clinical trials are Atrial Fibrillation, Tachycardia, and Shock, Septic. The leading clinical trial sponsors are AOP Orphan Pharmaceuticals AG, University Hospital, Caen, and Centre Hospitalier de Lens.

There are two hundred and forty-four US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Landiolol
TitleSponsorPhase
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With HypercontractilityCentre Hospitalier ArrasN/A
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With HypercontractilityCentre Hospitalier de BethuneN/A
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With HypercontractilityCentre Hospitalier de LensN/A

See all Landiolol clinical trials

Clinical Trial Summary for Landiolol

Top disease conditions for Landiolol
Top clinical trial sponsors for Landiolol

See all Landiolol clinical trials

US Patents for Landiolol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Landiolol   Get Started Free Branched 3-phenylpropionic acid derivatives and their use BAYER PHARMA AKTIENGESELLSCHAFT (Monheim, DE)   Get Started Free
Landiolol   Get Started Free Substituted pyridobenzodiazepinone-derivatives and use thereof Bayer Pharma Aktiengesellschaft (Berlin, DE)   Get Started Free
Landiolol   Get Started Free Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Get Started Free
Landiolol   Get Started Free 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Get Started Free
Landiolol   Get Started Free Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro- 1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient BAYER PHARMA AG (Berlin, DE)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Landiolol

Drugname Country Document Number Estimated Expiration Related US Patent
Landiolol African Regional IP Organization (ARIPO) AP3482 2031-04-13   Get Started Free
Landiolol Argentina AR085586 2031-04-13   Get Started Free
Landiolol Australia AU2012242122 2031-04-13   Get Started Free
Landiolol Brazil BR112013026466 2031-04-13   Get Started Free
Landiolol Canada CA2832970 2031-04-13   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKinsey
Mallinckrodt
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.